Horizon Pharma Plc Stock Net Income
HZNPDelisted Stock | USD 116.30 0.00 0.00% |
Horizon Pharma PLC fundamentals help investors to digest information that contributes to Horizon Pharma's financial success or failures. It also enables traders to predict the movement of Horizon Stock. The fundamental analysis module provides a way to measure Horizon Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Horizon Pharma stock.
Horizon |
Horizon Pharma PLC Company Net Income Analysis
Horizon Pharma's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Horizon Pharma Net Income | 521.48 M |
Most of Horizon Pharma's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Horizon Pharma PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Horizon Pharma PLC reported net income of 521.48 M. This is 52.8% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is 8.67% higher than that of the company.
Horizon Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Horizon Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Horizon Pharma could also be used in its relative valuation, which is a method of valuing Horizon Pharma by comparing valuation metrics of similar companies.Horizon Pharma is currently under evaluation in net income category among related companies.
Horizon Fundamentals
Return On Equity | 0.0854 | |||
Return On Asset | 0.0444 | |||
Profit Margin | 0.12 % | |||
Operating Margin | 0.18 % | |||
Current Valuation | 26.87 B | |||
Shares Outstanding | 229 M | |||
Shares Owned By Insiders | 1.18 % | |||
Shares Owned By Institutions | 98.82 % | |||
Number Of Shares Shorted | 7.1 M | |||
Price To Earning | 32.55 X | |||
Price To Book | 5.10 X | |||
Price To Sales | 6.93 X | |||
Revenue | 3.63 B | |||
Gross Profit | 2.8 B | |||
EBITDA | 1.11 B | |||
Net Income | 521.48 M | |||
Cash And Equivalents | 2.13 B | |||
Cash Per Share | 9.40 X | |||
Total Debt | 2.56 B | |||
Debt To Equity | 0.53 % | |||
Current Ratio | 3.96 X | |||
Book Value Per Share | 23.20 X | |||
Cash Flow From Operations | 1.26 B | |||
Short Ratio | 2.04 X | |||
Earnings Per Share | 1.88 X | |||
Price To Earnings To Growth | 1.00 X | |||
Target Price | 116.5 | |||
Number Of Employees | 2.19 K | |||
Beta | 1.01 | |||
Market Capitalization | 26.63 B | |||
Total Asset | 9.11 B | |||
Retained Earnings | 590.01 M | |||
Working Capital | 2.7 B | |||
Current Asset | 1.11 B | |||
Current Liabilities | 357.55 M | |||
Z Score | 7.48 | |||
Net Asset | 9.11 B |
About Horizon Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Horizon Pharma PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Horizon Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Horizon Pharma PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Horizon Stock
If you are still planning to invest in Horizon Pharma PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Horizon Pharma's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |